Back

JPPCM · Lens · A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia

PDF

Article · Volume 2, Issue 3 · pp. 94–95

A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia

Meghana Devulapalli1, Narasimha Kumar G.V2

  1. 1Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.
  2. 2Department of Pharmacology, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.

Abstract

Nevirapine is one of the first line agents of the anti-retroviral therapy (ART) used widely in the management of human immunodeficiency virus (HIV) infection and also in acquired immunodeficiency syndrome (AIDS). Anemia is often reported in the individuals taking ART. We report a case of Nevirapine induced autoimmune haemolytic anemia (AIHA). This case report creates awareness on the hematologic abnormality caused by the drug requiring immediate medical attention.

Keywords: Drug induced blood disorder; Drug rash; Altered hematology and Quality of life

The full text of this article is available as a PDF. Open the PDF.